The association between therapeutic plasma exchange and the risk of mortality among patients critically ill with COVID-19: a meta-analysis
Open Access
- 14 December 2021
- journal article
- review article
- Published by F1000 Research Ltd in F1000Research
- Vol. 10, 1280
Abstract
Background: Cytokine storm has been widely known to contribute to the development of the critical condition in patients with coronavirus disease 2019 (COVID-19), and studies had been conducted to assess the potential aspect of cytokine storm elimination by performing therapeutic plasma exchange (TPE). However, contradictory findings were observed. The objective of this study was to assess the association between TPE and the reduction of mortality of critically ill COVID-19 patients. Methods: A meta-analysis was conducted by collecting data from PubMed, Scopus, and Web of Science. Data on the mortality rate of critically ill COVID-19 patients treated with TPE plus standard of care and that of patients treated with standard of care alone were analyzed using a Z test. Results: We included a total of four papers assessing the association between TPE and the risk of mortality among critically ill COVID-19 patients. Our findings suggested that critically ill COVID-19 patients treated with TPE had lower risk of mortality compared to those without TPE treatment. Conclusion: Our study has identified the potential benefits of TPE in reducing the risk of mortality among critically ill COVID-19 patients.Keywords
This publication has 28 references indexed in Scilit:
- Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathologySeminars in Immunopathology, 2017
- Atypical haemolytic uraemic syndrome associated with a CD46 mutation triggered by Shigella flexneriClinical Kidney Journal, 2014
- Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analysesEuropean Journal of Epidemiology, 2010
- Plasma Exchange for Disseminated CryptococcosisAmerican Journal of Kidney Diseases, 2009
- Scales to Assess the Quality of Randomized Controlled Trials: A Systematic ReviewPhysical Therapy, 2008
- Consanguineous hemolytic uremic syndrome secondary to Escherichia coli O157:H7 infection treated with aggressive therapeutic plasma exchangeJournal of Clinical Apheresis, 2001
- An overview of current managementJournal of Clinical Apheresis, 1993
- [Plasmapheresis in the treatment of peripheral HIV neuropathy].1989
- [A case using plasmapheresis in treating infectious toxicosis in young infants].1988
- PARTIAL PLASMA EXCHANGE IN PATIENTS WITH AIDS AND KAPOSI'S SARCOMA. PLASMAPHERESIS IN AIDSAIDS Research, 1986